Sequent Scientific raises Rs 400 crore through QIP issue

27 May 2015 Evaluate

Sequent Scientific has raised Rs 400 crore by issuing equity shares through Qualified Institutional Placement (QIP). The company has issued 7,476,635 equity shares at Rs 535 per share, aggregating to Rs 400 crore.

The company will utilize QIP proceeds to meet its long-term funding requirements, including investments in R&D, new markets, capital expenditure and to meet general business requirements.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.


 

Viyash Scientific Share Price

198.25 4.15 (2.14%)
22-Jan-2026 10:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.50
Dr. Reddys Lab 1218.20
Cipla 1378.05
Zydus Lifesciences 885.05
Lupin 2181.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×